Real time PCR reconfirmed three novel clinical associations of parvovirus B19: Non-occlusive bowel gangrene, amegakaryocytic thrombocytopenia & myositis

Indian Journal of Medical Research

Volumn 142, Issue JULY, 2015, Pages 72-78

  Kishore, Janak ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; IMMUNOGLOBULIN M ANTIBODY;

ANEMIA; COLONY FORMING UNIT; DISEASE ASSOCIATION; GANGRENE; GENE AMPLIFICATION; GENE SEQUENCE; HEMATOLOGY; HUMAN; HUMAN PARVOVIRUS B19; IMMUNOLOGY; LETTER; MYOSITIS; NON OCCLUSIVE BOWEL GANGRENE; REAL TIME POLYMERASE CHAIN REACTION; RETICULOCYTOPENIA; THROMBOCYTOPENIA; TISSUE DISTRIBUTION; VIRUS REPLICATION; GENETICS; INFLAMMATORY BOWEL DISEASE; ISOLATION AND PURIFICATION; PATHOGENICITY; VIROLOGY;

GANGRENE; HUMANS; INFLAMMATORY BOWEL DISEASES; MYOSITIS; PARVOVIRUS B19, HUMAN; REAL-TIME POLYMERASE CHAIN REACTION; THROMBOCYTOPENIA;

EID: 84938702205     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: 10.4103/0971-5916.162132     Document Type: Letter

References (16)

1. Rahav G. Parvovirus B19infection--an emerging infectious disease? Isr Med Assoc J 2002; 4: 810-1.
2. Bock CT. Parvovirus B19:a new emerging pathogenic agent of inflammatory cardiomyopathy. Ernst Schering Res Found Workshop 2006; 55: 83-97.
3. Kishore J, Kapoor A. Erythrovirus B19 infection in humans. Indian J Med Res 2000; 112: 49- 64.
4. Heegaard ED, Brown KE. Human parvovirus B19. Clin Microbiol Rev 2002; 15: 485-505.
5. Kishore J, Das NR, Saxena R, Krishnani N. Novel detection of parvovirus B19 DNA and IgM antibodies in patients with non-occlusive gangrene of stomach & bowel. Indian J Med Res 2010; 131: 702-10.
6. Bhattacharyya J, Kumar R, Tyagi S, Kishore J, Mahapatra M, Choudhary VP. Human parvovirus B19-induced acquired pure amegakaryocytic thrombocytopenia. Br J hematol 2005; 128: 128-9.
7. Kishore J, Singh J.Detection of parvovirus B19 in a case of erythema infectiosum with myositis. Indian Pediatr 2006; 43: 814-7.
8. Finkel TH, Török TJ, Ferguson PJ, Durigon EL, Zaki SR, Leung DY, et al. Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent? Lancet 1994; 343: 1255-8.
9. Murer L, Zacchello G, Bianchi D, Dall’Amico R, Montini G, Andreetta B, et al. Thrombotic microangiopathy associated with parvovirus B 19 infection after renal transplantation. J Am Soc Nephrol 2000; 11: 1132-7.
10. Ammaturo C, De Rosa A, Morra C, Bassi U, Cerrato C, D’Eliso E, et al. Intestinal infarction: report of 98 cases. Chir Ital 2001; 53: 45-56.
11. Perri S, Lotti R, Procacciante F, Gabbrielli F, Nardi M, Amendolara M, et al. Intestinal infarction. Retrospective clinical study. Chir Ital 2001; 53: 57-64.
12. Crum-Cianflone NF.Bacterial, fungal, parasitic, and viral myositis.Clin Microbiol Rev 2008; 21: 473-94.
13. Koliou M, Karaoli E, Soteriades ES, Pavlides S, Bashiardes S, Christodoulou C. Acute hepatitis and myositis associated with erythema infectiosum by Parvovirus B19 in an adolescent. BMC Pediatr 2014; 14: 6.
14. Oliver ND, Millar A, Pendleton A. A case report on parvovirus b19 associated myositis. Case Rep Rheumatol 2012; 2012: 250-537.
15. Kishore J. Standardization of parvovirus B19 DNA extraction from serum and quantitative PCR. Indian J Pathol Microbiol 2005; 48: 522-5.
16. Brown KE, Young NS. Parvovirus B19 infection and hematopoiesis. Blood Rev 1995; 9: 176-82.